Entera Bio (ENTX) Short-Term Debt to Capital

Entera Bio Ltd - graphic logo of issuer ENTX

The market trend for the separate_debt_short_eq metric is 0.03, which correlates with the Entera Bio Ltd. (ENTX) strategy of developing oral delivery systems for hormones and large molecules to minimize risks associated with individual test failures. Despite regional volatility in Israel, the business's humanitarian profile eliminates sanction threats. The company's stability relies on its own R&D centers for unique protein delivery methods.

enterabio.com (ENTX) Ratio of Short-Term Indebtedness to Capital: for the period 07/04/2022 - 10/29/2026

Metric breakdowns and analytics for Entera Bio Corp (ENTX)

- price and consensus price forecast:
Stock Price Entera Bio Ltd.|ENTX - Fair Value Consensus
- market capitalization data:
Market Capitalization Entera Bio Ltd|ENTX - Enterprise Value
- book capitalization data:
Net Assets per Single Share Entera Bio|ENTX - Accounting Value of Company|Market Value to Book Value Ratio enterabio.com|ENTX - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Entera Bio Ltd.|ENTX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Entera Bio Ltd.|ENTX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Entera Bio Ltd|ENTX - Long-Term Debt|Company Current Liabilities Entera Bio
General company analysis:Entera Bio (ENTX)
Brand item of enterabio.com

For the Israeli Entera Bio Ltd. (ENTX), operating amid regional instability, liquidity control is critical for sustaining humanitarian developments. This ratio of short-term debt to equity reflects the company's reliance on quick borrowings relative to its own equity, where rising values signal increased debt risks. Analyzing the trend of this metric allows an investor to assess the resilience of the issuer's financial model to external shocks.

Competitors of Entera Bio Ltd.

Haleon Group (HLN) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Kenvue Health (KVUE)|Short-Term Debt to Capital VRNA (Verona Pharma plc)|jyongbio.com - Short-Term Debt to Capital|Short-Term Debt to Equity Ligand (LGND)|AMRX: Ratio of Short-Term Indebtedness to Capital|PRGO (Perrigo Company) - Short-Term Debt to Equity|Alvotech Biopharmaceuticals (ALVO) - Short-Term Debt to Equity Ratio|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com (GLPG)|ANI Pharmaceuticals, Inc. (ANIP) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital MNKD (MannKind Corp)|AMPH: Short-Term Debt to Equity|PCRX - Current Liabilities to Capital|Short-Term Debt to Equity Ratio ARS Pharmaceuticals SPRY|TBPH - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital Aquestive Therapeutics, Inc. AQST|scPharmaceuticals (SCPH) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TECX (Tectonic Therapeutic Inc.)|Current Liabilities to Capital TNXP|China SXT Pharmaceuticals (SXTC) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital eupraxiapharma.com (EPRX)|BHST: Short-Term Debt to Capital|Invizyne Technologies - Current Liabilities to Capital|Oramed Pharma (ORMP) - Short-Term Debt to Equity|MindWalk Therapeutics (HYFT) - Short-Term Debt to Capital Ratio|ABVC - Short-Term Debt to Equity Ratio|cumberlandpharma.com (CPIX) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital QNTM (Quantum BioPharma)|Current Liabilities to Capital FGEN|Telomir Pharma (TELO) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital ranitherapeutics.com (RANI)|Short-Term Debt to Capital SNYR (Synergy CHC)|RLYB - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Lexaria (LEXX)|PULM - Ratio of Short-Term Indebtedness to Capital|ftzy.com.cn (PTHL) - Short-Term Debt to Capital|Aptorum Group (APM) - Short-Term Debt to Equity|LYRA: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient IBO|TNF Pharmaceuticals - Short-Term Debt to Equity|Current Liabilities to Capital cbdmd.com YCBD|Short-Term Debt to Equity Ratio PainReform Limited|Altamira Therapeutics Ltd - Ratio of Short-Term Indebtedness to Capital|LIPO - Short-Term Debt to Equity|optinose.com (OPTN) - Short-Term Debt to Equity|PIRS - Short-Term Debt to Equity Ratio|Procaps Group (PROC) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital Petros (PTPI)|Short-Term Debt to Capital Ratio Qilian International Corp (QLI)|SLRN (Acelyrin, Inc.) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient tffpharma.com (TFFP)